2021•Transfusion MedicineRequires access

The Blood Supply

Jeffrey McCullough

Open publisher page 4 citations

Abstract

Blood transfusion occurs in all parts of the world, but the availability, quality, and safety of the blood depends on the general status of medical care in that area. In contrast with the worldwide supply, the United States (US) blood supply is provided by many different organizations with different organizational structures and philosophies. The US blood collection system is heterogeneous because blood centers developed for a variety of reasons mostly during the 1940s and 1950s. Most plasma for transfusion is a by-product of whole blood. One of the major issues in blood inventory management is the attitude of blood donors. In the past, blood centers carried out a variety of activities that provided services in addition to the blood components. Organizations and facilities need US Food and Drug Administration licenses for either plasma collection or the manufacture of derivatives from plasma, or both, depending on the activities they conduct.

About this research paper

What this paper is about

Blood transfusion occurs in all parts of the world, but the availability, quality, and safety of the blood depends on the general status of medical care in that area. In contrast with the worldwide supply, the United States (US) blood supply is provided by many different organizations with different organizational structures and philosophies. The US blood collection system is heterogeneous because blood centers developed for a variety of reasons mostly during the 1940s and 1950s. Most plasma for transfusion is a by-product of whole blood. One of the major issues in blood inventory management is the attitude of blood donors. In the past, blood centers carried out a variety of activities that provided services in addition to the blood components. Organizations and facilities need US Food and Drug Administration licenses for either plasma collection or the manufacture of derivatives from plasma, or both, depending on the activities they conduct.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Blood transfusion occurs in all parts of the world, but the availability, quality, and safety of the blood depends on the general status of medical care in that area. In contrast with the worldwide supply, the United States (US) blood supply is provided by many different organizations with different organizational structures and philosophies. The US blood collection system is heterogeneous because blood centers developed for a variety of reasons mostly during the 1940s and 1950s. Most plasma for transfusion is a by-product of whole blood. One of the major issues in blood inventory management is the attitude of blood donors. In the past, blood centers carried out a variety of activities that provided services in addition to the blood components. Organizations and facilities need US Food and Drug Administration licenses for either plasma collection or the manufacture of derivatives from plasma, or both, depending on the activities they conduct.

Key concepts: Blood collection, Blood supply, Blood product, Food and drug administration, Blood transfusion, Business, Blood bank, Variety (cybernetics)

Related papers

Back to paper searchBrowse research topicsOriginal source
The Blood Supply — Research Paper | ScholarLens